Safety Profile from Clinical Evaluation
Safety outcomes were assessed in a clinical evaluation,
including adverse events and device-related observations.
Simplified Application Approach
Voferon WI is designed to support a simplified application process
by using a simplified application approach that does not require additional delivery components such as pumps or catheters Clinical use should be determined based on procedural requirements and clinician judgment.
Clinical Data Source:
Data on safety outcomes are derived from a clinical evaluation of Voferon WI,
including assessment of adverse events and device-related observations.
References:
Bianconi M et al. Pharmacokinetics and efficacy of ropivacaine continuous wound infusion. Br J Anaesth. 2003.
Abate SM et al. Efficacy and safety of wound infiltration modalities for postoperative pain management. 2022.
The presented information includes both clinical evaluation data and published literature
and should be interpreted in the context of study design and clinical setting.